Articles
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last related news
November 9, 2022
Brazil: Patent Litigation 2023 – IAM Media
Our partner Claudio Barbosa and our Attorney at Law Viviane Trojan are the authors of the article “Brazil: Patent Litigation”, published in the Global Patent … Brazil: Patent Litigation 2023 – IAM Media
August 15, 2022
Protecting Plant Varieties in Brazil for FloraCulture Magazine
Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant … Protecting Plant Varieties in Brazil for FloraCulture Magazine
February 14, 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide